Monlunabant
A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
Inversago Pharma · Phase 1 · Completed · Enrollment 37
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Monlunabant
Inversago Pharma · Phase 1 · Completed · Enrollment 37
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.